Tag: Supriya Lifescience

Public problems from the Supriya Lifescience active pharmaceutical material supplier witnessed strong demand from investors because of the subscription offer of 71.36 times. It accepted an offer for 103.66 crore equity shares against the size of IPO 1.45 crore equity shares on December 20, the last day of the offer. […]

Supriya Lifescience Ltd, an Indian producer and dealer of lively pharmaceutical ingredients (APIs), will open its Rs 700-crore preliminary public offering (IPO) on December 16. The trouble will near on December 20. The organisation has a gap product basket of 38 APIs throughout antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic […]